HematologyNews.net

Hematology Xagena

Search results for "Glivec"

Researchers have identified a new pathway in the progression of chronic myelogenous leukemia ( CML ). They also discovered that an extract from the root of a common ornamental plant can suppress the p ...


Researchers at The University of Texas M. D. Anderson Cancer Center found that AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Imatinib ( Gleevec/Gli ...


The results from five studies highlighting new advances in the treatment of chronic myeloid leukemia ( CML ) – a slow-progressing, malignant bone marrow cancer – have been presented at the 47th Annual ...


Nilotinib ( AMN107, Tasigna ) appears to offer striking benefits in patients with chronic myelogenous leukemia ( CML ) who are resistant to Imatinib ( Gleevec / Glivec ), the standard therapy for this ...


Dasatinib ( Sprycel ) reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Imatinib ( Gleevec / Glivec ), which is considered the standard of treatment f ...


A study of the Oregon Health & Science University ( OHSU ) Cancer Institute has shown that the overall survival of most people with chronic myelogenous leukemia ( CML ) treated with Imatinib ( Gleeve ...


A 5-year follow-up of patients with chronic myeloid leukemia ( CML ) who began continuous treatment with Imatinib ( Glivec / Gleevec ) reports that the drug can induce durable hematologic and cytogene ...


The drug Imatinib mesylate, more commonly known as Gleevec ( Europe: Glivec ), proves safe and effective over the long term in patients with an advanced form of chronic myeloid leukemia ( CML ). A ...


Activation of LYN kinase is associated with resistance to Imatinib ( Gleevec, Glivec ) in patients with chronic myelogenous leukemia ( CML ).Imatinib is the standard therapy for newly diagnosed CML pa ...


Treating pregnant women with leukaemia can be quite difficult as studies suggest that certain therapies can harm developing fetuses. According to the results of a study prepublished in the Blood, the ...


A rare disorder caused by an excess of two types of immune cells, the mast cell found in various tissues and its blood-based twin, the basophil, has successfully been treated with a cancer drug, repor ...


Treating pregnant women with leukaemia can be quite difficult as studies suggest that certain therapies can harm developing fetuses. According to the results of a study prepublished in the Blood, the ...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Glivec ( Imati ...


The Pharmacovigilance Risk Assessment Committee ( PRAC ) of the European Medicines Agency ( EMA ) has concluded its review of Iclusig ( Ponatinib ) under the Article 20 referral procedure and has reco ...